news
Researchers have found that the spasmolytic drug hymecromone can suppress…
1 March 2021 | By Victoria Rees (Drug Target Review)
Researchers have found that the spasmolytic drug hymecromone can suppress astrocyte inflammatory responses, meaning it could be used to combat Alzheimer's disease.